Subscribe To
LMAT / Is This Small-Cap Dividend Stock a Buy?
LMAT News
By GlobeNewsWire
November 3, 2023
LeMaitre to Participate at Upcoming Investor Conferences in November
BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in th more_horizontal
By Seeking Alpha
November 1, 2023
LeMaitre Vascular, Inc. (LMAT) Q3 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Fin more_horizontal
By Zacks Investment Research
October 23, 2023
PETQ or LMAT: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either PetIQ (PETQ) or LeMaitre Vascular (LMAT). But which of the more_horizontal
By GlobeNewsWire
September 21, 2023
LeMaitre to Present at the 2023 Cantor Global Healthcare Conference
BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will presen more_horizontal
By The Motley Fool
September 1, 2023
Looking for Dividend Growth? Buy This Little-Known Healthcare Stock
LeMaitre Vascular's sales and profits surged in the second quarter. The company's dividend is supported by earnings. more_horizontal
By Seeking Alpha
August 24, 2023
LeMaitre: Record Quarter, ASPs And Volumes Ratcheting Higher Equals Qualified Growth Outlook
LeMaitre Vascular's stock offers attractive long-term investment prospects, with recent consolidations offering an entry point for investors. The comp more_horizontal
By Seeking Alpha
August 1, 2023
LeMaitre Vascular, Inc. (LMAT) Q2 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Finan more_horizontal
By Zacks Investment Research
August 1, 2023
LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Beat Estimates
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares t more_horizontal